Copyright
©The Author(s) 2015.
World J Med Genet. Nov 27, 2015; 5(4): 52-59
Published online Nov 27, 2015. doi: 10.5496/wjmg.v5.i4.52
Published online Nov 27, 2015. doi: 10.5496/wjmg.v5.i4.52
Table 2 Hereditary breast and ovarian cancer syndrome pre and post treatment options with reproductive implications
| Genetic counseling needs for AYAs with a new cancer diagnosis | Genetic counseling needs for AYA cancer survivors |
| Surgical treatment (e.g., contralateral prophylactic mastectomy at the time of initial diagnosis for BRCA carriers) | Risk reduction surgeries post treatment (e.g., salpingectomy vs bilateral salpingo oophorectomy for BRCA carriers) |
| Chemotherapy (e.g., clinical trials focused on poly ADP ribose polymerase inhibitors for BRCA carriers) | Use of Tamoxifen for management of disease recurrence among ER + BRCA carriers. |
- Citation: Quinn GP, Peshkin BN, Sehovic I, Bowman M, Tamargo C, Vadaparampil ST. Oncofertility in adolescent and young adult hereditary cancer: Considerations for genetics professionals. World J Med Genet 2015; 5(4): 52-59
- URL: https://www.wjgnet.com/2220-3184/full/v5/i4/52.htm
- DOI: https://dx.doi.org/10.5496/wjmg.v5.i4.52